Correlation Between Milestone Pharmaceuticals and Hookipa Pharma
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Hookipa Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Hookipa Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Hookipa Pharma, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Hookipa Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Hookipa Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Hookipa Pharma.
Diversification Opportunities for Milestone Pharmaceuticals and Hookipa Pharma
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Milestone and Hookipa is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Hookipa Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hookipa Pharma and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Hookipa Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hookipa Pharma has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Hookipa Pharma go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Hookipa Pharma
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 0.78 times more return on investment than Hookipa Pharma. However, Milestone Pharmaceuticals is 1.29 times less risky than Hookipa Pharma. It trades about -0.02 of its potential returns per unit of risk. Hookipa Pharma is currently generating about -0.03 per unit of risk. If you would invest 475.00 in Milestone Pharmaceuticals on August 26, 2024 and sell it today you would lose (291.00) from holding Milestone Pharmaceuticals or give up 61.26% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Hookipa Pharma
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Hookipa Pharma |
Milestone Pharmaceuticals and Hookipa Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Hookipa Pharma
The main advantage of trading using opposite Milestone Pharmaceuticals and Hookipa Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Hookipa Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hookipa Pharma will offset losses from the drop in Hookipa Pharma's long position.The idea behind Milestone Pharmaceuticals and Hookipa Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Hookipa Pharma vs. Eliem Therapeutics | Hookipa Pharma vs. HCW Biologics | Hookipa Pharma vs. Scpharmaceuticals | Hookipa Pharma vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |